Clindamycin hydrochloride

Hazard statements (CLP)

H317, H319, H362

Code

Statements

H317

May cause an allergic skin reaction

SECTION 2: Hazards identification

2.1 Classification of the substance or mixture

Eye irritation, (Category 2) H319: Causes serious eye irritation. Skin sensitization, (Category 1) H317: May cause an allergic skin reaction. Effects on or via lactation H362: May cause harm to breast-fed children.

Signal word

Warning Warning

Hazard statements

H317 May cause an allergic skin reaction. H319 Causes serious eye irritation. H362 May cause harm to breast-fed children. H317 May cause an allergic skin reaction. H362 May cause harm to breast-fed children.

Precautionary statements

P260 Do not breathe dust. P263 Avoid contact during pregnancy and while nursing. P280 Wear protective gloves/ eye protection/ face protection. P302 + P352 IF ON SKIN: Wash with plenty of water. P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P308 + P313 IF exposed or concerned: Get medical advice/ attention. P302 + P352 IF ON SKIN: Wash with plenty of water.

Supplemental label elements

none Reduced Labeling (<= 125 ml) none

Other hazards

This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher

ECOLOGICAL INFORMATION

The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.

TOXICOLOGICAL INFORMATION

The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.